Haleon Plc - ADR (HLN1N)
BMV
Closed
Aug 21, 2026
Day's Range
171.0052 wk Range
159.85Overview - HLN1N - Haleon Plc - ADR
Key Statistics
Valuation
Enterprise Value
17.71T
P/E (Trailing)
‪20.40‬
Price / Sales (TTM)
‪67.44‬
Price / Book
‪2.00‬
EV / EBITDA
‪269.36‬
Profitability
Gross Margin
‪55.38%‬
Profit Margin
‪14.55%‬
Operating Margin
‪23.93%‬
Return on Assets
‪5.08%‬
Return on Equity
‪10.09%‬
Ownership
Shares Outstanding
8.90B
Float
4.42B
Held by Insiders
‪0.01%‬
Held by Institutions
‪13.54%‬
Price stats
Beta
‪0.24‬
50-Day Avg
‪166.26‬
200-Day Avg
‪172.87‬
Dividends
Payout Ratio
‪39.53%‬
Frequency
Semi-Annual
Peers - HLN1N - Haleon Plc - ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BMV.
Profile Summary - HLN1N - Haleon Plc - ADR
About
Haleon Plc - ADR represents an American Depositary Receipt for Haleon Plc, a company known for its focus on consumer healthcare products. ADRs are traded on U.S. stock exchanges and allow American investors to invest in non-U.S. companies without dealing with foreign transactions. Haleon Plc specializes in providing…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
